Q2 2025 Holdings
Filed 2025-08-28 | 477 holdings | $1.1B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Inhibrx Biosciences Inc(INBX) | Common Stock | 45720N103 | $41.5K | 2,907 | 0.0% |
| Spdr S&P Biotech ETF(XBI) | ETP | 78464A870 | $42.1K | 508 | 0.0% |
| Omniab Inc(OABI) | Common Stock | 68218J103 | $42.8K | 24,571 | 0.0% |
| Neurogene Inc(NGNE) | Common Stock | 64135M105 | $42.8K | 2,864 | 0.0% |
| Tevogen BIO Holdings Inc(TVGN) | Common Stock | 88165K101 | $46.2K | 36,934 | 0.0% |
| Maxcyte Inc(MXCT) | Common Stock | 57777K106 | $46.6K | 21,354 | 0.0% |
| Third Harmonic BIO Inc(THRD) | Common Stock | 88427A107 | $49.2K | 9,064 | 0.0% |
| Allogene Therapeutics Inc(ALLO) | Common Stock | 019770106 | $49.6K | 43,931 | 0.0% |
| Compass Pathways PLC(CMPS) | ADR | 20451W101 | $51.2K | 18,272 | 0.0% |
| Entrada Therapeutics Inc(TRDA) | Common Stock | 29384C108 | $51.2K | 7,623 | 0.0% |
| Foghorn Therapeutics Inc(FHTX) | Common Stock | 344174107 | $52.6K | 11,195 | 0.0% |
| Alpha Teknova Inc(TKNO) | Common Stock | 02080L102 | $52.7K | 10,733 | 0.0% |
| Annexon Inc(ANNX) | Common Stock | 03589W102 | $52.9K | 22,036 | 0.0% |
| Rocket Pharmaceuticals Inc(RCKT) | Common Stock | 77313F106 | $53.0K | 21,639 | 0.0% |
| Cartesian Therapeutics Inc(RNAC) | Common Stock | 816212302 | $54.2K | 5,213 | 0.0% |
| Silence Therapeutics PLC(SLN) | ADR | 82686Q101 | $54.8K | 9,446 | 0.0% |
| Vanda Pharmaceuticals Inc(VNDA) | Common Stock | 921659108 | $55.9K | 11,837 | 0.0% |
| Alumis Inc(ALMS) | Common Stock | 022307102 | $57.6K | 19,197 | 0.0% |
| Olema Pharmaceuticals Inc(OLMA) | Common Stock | 68062P106 | $58.5K | 13,742 | 0.0% |
| Astria Therapeutics Inc(CATBUSD) | Common Stock | 04635X102 | $60.8K | 11,335 | 0.0% |
| Bicycle Therapeutics PLC(BCYC) | ADR | 088786108 | $61.6K | 8,866 | 0.0% |
| Atea Pharmaceuticals Inc(AVIR) | Common Stock | 04683R106 | $61.9K | 17,188 | 0.0% |
| Corvus Pharmaceuticals Inc(CRVS) | Common Stock | 221015100 | $62.0K | 15,488 | 0.0% |
| Invesco Senior Loan ETF(BKLN) | ETP | 46138G508 | $62.2K | 2,972 | 0.0% |
| Altimmune Inc(ALT) | Common Stock | 02155H200 | $63.0K | 16,290 | 0.0% |
| Exact Sciences Corp(EXAS) | Common Stock | 30063P105 | $64.6K | 1,216 | 0.0% |
| Humacyte Inc(HUMA) | Common Stock | 44486Q103 | $65.1K | 31,155 | 0.0% |
| Prime Medicine Inc(PRME) | Common Stock | 74168J101 | $65.1K | 26,370 | 0.0% |
| Amarin Corp PLC(EH3) | ADR | 023111404 | $65.2K | 4,021 | 0.0% |
| Terns Pharmaceuticals Inc(TERN) | Common Stock | 880881107 | $65.4K | 17,541 | 0.0% |
| Prothena Corp PLC(PRTA) | Common Stock | G72800108 | $65.6K | 10,811 | 0.0% |
| Absci Corp(ABSI) | Common Stock | 00091E109 | $65.8K | 25,620 | 0.0% |
| Aquestive Therapeutics Inc(AQST) | Common Stock | 03843E104 | $66.0K | 19,950 | 0.0% |
| Rigel Pharmaceuticals Inc(RIGL) | Common Stock | 766559702 | $67.2K | 3,590 | 0.0% |
| Lexicon Pharmaceuticals Inc(LXRX) | Common Stock | 528872302 | $69.0K | 72,943 | 0.0% |
| Maravai Lifesciences Hldgs(MRVI) | Common Stock | 56600D107 | $69.7K | 28,917 | 0.0% |
| Arcturus Therapeutics Holdin(ARCT) | Common Stock | 03969T109 | $70.9K | 5,447 | 0.0% |
| Erasca Inc(ERAS) | Common Stock | 29479A108 | $72.3K | 56,897 | 0.0% |
| Tectonic Therapeutic Inc(TECX) | Common Stock | 878972108 | $74.5K | 3,750 | 0.0% |
| Pulse Biosciences Inc(PLSE) | Common Stock | 74587B101 | $75.5K | 5,000 | 0.0% |
| Solid Biosciences Inc(SLDB) | Common Stock | 83422E204 | $75.8K | 15,569 | 0.0% |
| Iteos Therapeutics Inc(5E7) | Common Stock | 46565G104 | $76.6K | 7,687 | 0.0% |
| Pacific Biosciences of Calif(PACB) | Common Stock | 69404D108 | $77.1K | 62,190 | 0.0% |
| Aura Biosciences Inc(AURA) | Common Stock | 05153U107 | $78.0K | 12,453 | 0.0% |
| Savara Inc(SVRA) | Common Stock | 805111101 | $79.1K | 34,714 | 0.0% |
| Kanzhun LTD(BZ) | ADR | 48553T106 | $82.1K | 4,600 | 0.0% |
| Tourmaline BIO Inc(TRML) | Common Stock | 89157D105 | $82.5K | 5,159 | 0.0% |
| Regenxbio Inc(RGNX) | Common Stock | 75901B107 | $82.7K | 10,075 | 0.0% |
| Galapagos NV(GLPG) | ADR | 36315X101 | $83.3K | 2,976 | 0.0% |
| Rapport Therapeutics Inc(RAPP) | Common Stock | 75383L102 | $83.3K | 7,330 | 0.0% |